The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2a safety run-in and preliminary efficacy study of liposomal gemcitabine (FF-10832) in combination with pembrolizumab in patients with advanced solid tumors.
 
Corey J. Langer
Honoraria - AstraZeneca; Genentech/Roche; Lilly/ImClone; Merck; Takeda Science Foundation
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Gilead Sciences; Lilly/ImClone; Merck; Novocure; Pfizer; Regeneron; Takeda
Research Funding - Advantagene (Inst); Amgen; Ariad (Inst); AstraZeneca; Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte; Inovio Pharmaceuticals (Inst); Johnson & Johnson/Janssen; Lilly; Merck (Inst); Stem CentRx (Inst); Trizell (Inst)
Other Relationship - Amgen; Lilly; OncoCyte; Peregrine Pharmaceuticals; Summit Therapeutics; Synta
 
Brendan D. Curti
Honoraria - Clinigen Group; Sanofi
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb (Inst); Clinigen Group (Inst)
Patents, Royalties, Other Intellectual Property - Biomarkers for OX40 response (Inst)
 
Charles Michael Farber
Consulting or Advisory Role - Abbvie/Genmab
Speakers' Bureau - Abbvie/Genmab; BeiGene; Genentech; Incyte/MorphoSys; Kite/Gilead; Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Abbvie/Genmab; BeiGene; Genentech Foundation; Incyte/MorphoSys; Kite/Gilead; Seattle Genetics/Astellas
 
Catherine A. Wheeler
Consulting or Advisory Role - Fujifilm; KisoJi Biotechnology
Travel, Accommodations, Expenses - Fujifilm
 
David S. Wages
Stock and Other Ownership Interests - iSpecimen
Consulting or Advisory Role - Acerta Pharma/AstraZeneca; Fujifilm; Marker Therapeutics; Myovant Sciences; Nested; TD2
 
Takeshi Matsumoto
Employment - Fujifilm
Honoraria - Fujifilm
Research Funding - Fujifilm
Travel, Accommodations, Expenses - Fujifilm
 
Susumu Shimoyama
Employment - Fujifilm
Leadership - Fujifilm
Patents, Royalties, Other Intellectual Property - I report patents, WO/2008/026584, WO/2019/244979, WO/2020/071349, WO/2021/060307, WO/2021/125229, WO/2022/250013, WO/2022/250015, PCT/JP2023/041699
 
Mikinaga Mori
Employment - Fujifilm
Leadership - Fujifilm
 
Naoki Yamada
Employment - FUJIFILM Pharmaceutical U.S.A., Inc.
Patents, Royalties, Other Intellectual Property - FUJIFILM Pharmaceutical U.S.A., Inc.
 
Ruth Ann Subach
Employment - Fujifilm
Stock and Other Ownership Interests - Pfizer; Trevena
Travel, Accommodations, Expenses - Fujifilm
 
Timothy Madden
Employment - Fujifilm; Fujifilm (I)
Consulting or Advisory Role - TD2/Volastra
Patents, Royalties, Other Intellectual Property - 60 patents held from my previous work as a faculty member at the University of Texas MD Anderson Cancer Center
Travel, Accommodations, Expenses - Fuji Pharma (I); Fujifilm
 
Mary Johansen
Employment - Fujifilm; Fujifilm (I)
Leadership - Fujifilm (I)
Stock and Other Ownership Interests - Reata Pharmaceuticals (I)
Consulting or Advisory Role - Fujifilm; Fujifilm (I)
Patents, Royalties, Other Intellectual Property - Reata Pharmaceuticals (I)
Travel, Accommodations, Expenses - Fujifilm; Fujifilm (I)
 
Gary Maier
Consulting or Advisory Role - Fujifilm
 
Kin Cheung
Stock and Other Ownership Interests - Moderna Therapeutics (I)
Consulting or Advisory Role - Fujifilm Pharmaceutical, USA; Helio Health; IFOPA; Mebias; PureTech; Urica Therapeutic
Research Funding - Boston Children's Hospital
Travel, Accommodations, Expenses - Fujifilm Pharmaceutical, USA
 
Marya F. Chaney
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Matt D. Galsky
Stock and Other Ownership Interests - Rappta Therapeutics
Consulting or Advisory Role - Abbvie; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Curis; Daiichi Sankyo Europe GmbH; EMD Serono; Gilead Sciences; Janssen; Merck; Pfizer; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792